Showing results (271-280 of 316) with videos related to
Sort By:
Pageof 32
The Journal of Investigative Dermatology|November 5, 1997
Linkage studies in erythrokeratodermias: fine mapping, genetic heterogeneity and analysis of candidate genesG Richard, J P Lin, L Smith, et al.Journal of Affective Disorders|January 2, 2023
Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II StudyJianmeng Song, Benoit H Mulsant, Marcos Sanches, et al.Journal of Psychiatric Research|December 19, 2022
Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trialAlastair J Flint, Kathleen S Bingham, George S Alexopoulos, et al.Brain Injury|August 20, 2015
Pilot feasibility of an mHealth system for conducting ecological momentary assessment of mood-related symptoms following traumatic brain injuryShannon B Juengst, Kristin M Graham, I Wayan Pulantara, et al.The EMBO Journal|August 1, 1985
Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycleP H Rabbitts, J V Watson, A Lamond, et al.JAMA|April 1, 1992
Spectrum of disease in persons with human immunodeficiency virus infection in the United StatesK M Farizo, J W Buehler, M E Chamberland, et al.Molecular Psychiatry|March 20, 2024
Effect of olanzapine exposure on relapse and brain structure in patients with major depressive disorder with psychotic featuresHelena K Kim, Aristotle N Voineskos, Nicholas H Neufeld, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 3, 2020
Effect of Older vs Younger Age on Anthropometric and Metabolic Variables During Treatment of Psychotic Depression With Sertraline Plus Olanzapine: The STOP-PD II StudyAlastair J Flint, Anthony J Rothschild, Ellen M Whyte, et al.Human Psychopharmacology|April 11, 2016
SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD studySimon J C Davies, Benoit H Mulsant, Alastair J Flint, et al.Clinical Pharmacokinetics|May 15, 2015
The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PDSimon J C Davies, Benoit H Mulsant, Alastair J Flint, et al.Pageof 32